Search

everythinglearnresearchcommunity

for

Search:↓

Understanding hair biology is key to developing better treatments for hair and scalp issues.

Estrogen can temporarily slow down hair growth but this can be reversed.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Hair growth-related cells need the enzyme SCD1 to help maintain the area that supports hair growth.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Both mouse and rat models are effective for testing alopecia areata treatments.

Activin B helps start and grow hair follicles in mice.

Bioluminescence imaging can track hair follicle cells and help study hair regrowth.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Mice hair growth patterns get more complex with age and can change with events like pregnancy or injury.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Bicalutamide may help treat female pattern hair loss.

A woman with anorexia improved significantly after being treated for scurvy with vitamin C, despite not showing typical scurvy symptoms.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.